|
EP1712226A3
(en)
*
|
1996-04-05 |
2007-03-21 |
The General Hospital Corporation |
Treatment of a Hemoglobinopathy
|
|
US8128963B2
(en)
|
1996-09-27 |
2012-03-06 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating ischemic disorders using carbon monoxide
|
|
US6315995B1
(en)
*
|
1996-09-27 |
2001-11-13 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating an ischemic disorder and improving stroke outcome
|
|
JP2002509757A
(ja)
*
|
1998-04-01 |
2002-04-02 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
体外血液循環を受ける患者において血栓症を阻害するための方法
|
|
US7678390B2
(en)
|
1999-04-01 |
2010-03-16 |
Yale University |
Carbon monoxide as a biomarker and therapeutic agent
|
|
FR2816212A1
(fr)
*
|
2000-11-03 |
2002-05-10 |
Air Liquide Sante Int |
Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
|
|
US20030198639A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Frenette Paul S. |
Methods of treating sickle cell disease
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
MXPA03012031A
(es)
*
|
2001-06-21 |
2005-07-01 |
Univ Yale |
El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis.
|
|
US6472390B1
(en)
*
|
2001-11-13 |
2002-10-29 |
Duke University |
Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
|
|
JP2005519928A
(ja)
|
2002-02-04 |
2005-07-07 |
ハース，ベルナー |
Ｃｏ放出能力を有する化合物の投与によって哺乳動物を治療する方法と、ｃｏ放出能力を有する化合物ならびにその医薬組成物
|
|
EA200401070A1
(ru)
*
|
2002-02-13 |
2005-02-24 |
Бет Изрейэл Диконисс Медикал Сентер, Инк. |
Способы лечения сосудистых заболеваний
|
|
CA2481972A1
(en)
|
2002-04-15 |
2003-10-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods of treating ileus
|
|
US8097585B2
(en)
|
2002-04-15 |
2012-01-17 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
|
|
RS91104A
(sr)
|
2002-04-15 |
2007-02-05 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education, |
Postupci za lečenje nekrotizujućeg enterokolitisa
|
|
UA83465C2
(uk)
|
2002-05-17 |
2008-07-25 |
Йельский Университет |
Спосіб лікування гепатитів монооксидом вуглецю
|
|
DE10230165A1
(de)
|
2002-07-04 |
2004-01-15 |
Ino Therapeutics Gmbh |
Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
|
|
AU2003283982A1
(en)
*
|
2002-11-07 |
2004-06-03 |
University Of Pittsburgh Of The Commonwealth System Of High Education |
Treatment for hemorrhagic shock
|
|
AU2004283729A1
(en)
*
|
2003-10-22 |
2005-05-06 |
Fred Hutchinson Cancer Research Center |
Methods, compositions and devices for inducing stasis in cells
|
|
EP1552840A1
(en)
*
|
2004-01-07 |
2005-07-13 |
Aga Ab |
Use of a xenon/carbon monoxide mixture for the protection of cells
|
|
PL1934236T3
(pl)
|
2005-09-02 |
2013-04-30 |
Glycomimetics Inc |
Heterobifunkcjonalne inhibitory pan-selektyny
|
|
US8895510B2
(en)
|
2008-04-08 |
2014-11-25 |
Glycomimetics, Inc. |
Pan-selectin inhibitor with enhanced pharmacokinetic activity
|
|
EP2356224A4
(en)
*
|
2008-11-10 |
2012-12-26 |
Sinai School Medicine |
METHOD OF INHIBITING WEB TREATMENT IN CONNECTION WITH INFLAMMATION THROUGH NEUTROPHILACTIVITY INHIBITION
|
|
CN101732348B
(zh)
*
|
2008-11-11 |
2015-01-14 |
威世药业（如皋）有限公司 |
牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
|
|
WO2012037034A1
(en)
|
2010-09-14 |
2012-03-22 |
Glycomimetics, Inc. |
E-selectin antagonists
|
|
PT2699242T
(pt)
|
2011-04-19 |
2018-01-22 |
Alfama Inc |
Moléculas de libertação de monóxido de carbono e utilizações das mesmas
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
WO2013096926A1
(en)
|
2011-12-22 |
2013-06-27 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
|
JP5967631B2
(ja)
|
2012-04-27 |
2016-08-10 |
学校法人日本大学 |
上皮及び内皮損傷の治療剤
|
|
PT2928476T
(pt)
|
2012-12-07 |
2018-05-10 |
Glycomimetics Inc |
Compostos, composições e métodos que utilizam antagonistas de e-selectina para mobilização de células hematopoiéticas
|
|
WO2016089872A1
(en)
|
2014-12-03 |
2016-06-09 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
|
|
US11291678B2
(en)
|
2016-03-02 |
2022-04-05 |
Glycomimetics, Inc |
Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
|
|
JP2019524791A
(ja)
|
2016-08-08 |
2019-09-05 |
グリコミメティクス， インコーポレイテッド |
Ｅ−セレクチンの阻害剤もしくはｃｘｃｒ４の阻害剤との、またはｅ−セレクチンおよびｃｘｃｒ４両方のヘテロ二機能性阻害剤とのｔ細胞チェックポイント阻害剤の組み合わせ
|
|
US11072625B2
(en)
|
2016-10-07 |
2021-07-27 |
Glycomimetics, Inc. |
Highly potent multimeric e-selectin antagonists
|
|
CA3054605A1
(en)
|
2017-03-15 |
2018-09-20 |
Glycomimetics, Inc. |
Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
|
|
US11712446B2
(en)
|
2017-11-30 |
2023-08-01 |
Glycomimetics, Inc. |
Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
|
|
BR112020013198A2
(pt)
|
2017-12-29 |
2020-12-01 |
Glycomimetics, Inc. |
inibidores heterobifuncionais de e-selectina e galectina-3
|
|
KR20200128025A
(ko)
|
2018-03-05 |
2020-11-11 |
글리코미메틱스, 인크. |
급성 골수성 백혈병 및 관련 병태의 치료 방법
|
|
WO2020139962A1
(en)
|
2018-12-27 |
2020-07-02 |
Glycomimetics, Inc. |
Heterobifunctional inhibitors of e-selectin and galectin-3
|
|
US20230263832A1
(en)
*
|
2020-07-10 |
2023-08-24 |
Children's Medical Center Corporation |
Targeted drug delivery to sites of intravascular occlusion
|